
{
    "credit": [
        {
            "email": "pommier@nih.gov",
            "name": "Yves Pommier",
            "typeEntity": "Person",
            "typeRoles": [
            ]
        }
    ],
    "labels": {
        "topic": [
            {
                "term": "Biomarkers",
                "uri": "http://edamontology.org/topic_3360"
            },
            {
                "term": "Pharmacogenomics",
                "uri": "http://edamontology.org/topic_0208"
            },
            {
                "term": "Oncology",
                "uri": "http://edamontology.org/topic_2640"
            }
        ]
    },
    "publication": [
        {
            "doi": "10.1158/1078-0432.CCR-19-0419",
            "pmcid": "PMC6801079",
            "pmid": "31409613"
        }
    ],
    "summary": {
        "biotoolsCURIE": "biotools:RESULTSCellMinerCDB",
        "biotoolsID": "RESULTSCellMinerCDB",
        "description": "> MEDIUM CONFIDENCE! | > COMMON LINK WITH (PUB. & NAME DIFFERENT) bio.tools/CellMinerCDB (DISCOVER.NCI.NIH.GOV/cellminercdb), bio.tools/mammalian_gene_collection (NCI.NIH.GOV), bio.tools/rcellminer (NCI.NIH.GOV/cellminer), bio.tools/cgap (NCI.NIH.GOV), bio.tools/pid (NCI.NIH.GOV) | > CORRECT NAME OF TOOL COULD ALSO BE 'DESIGN:CellMinerCDB', 'indenoisoquinolines', 'LMP400 olaparib', 'LMP400' | The Indenoisoquinoline TOP1 Inhibitors Selectively Target Homologous Recombination-Deficient and Schlafen 11-Positive Cancer Cells and Synergize with Olaparib | CellMiner Cross Database (CellMinerCDB) is the first web application to allow translational researchers to conduct analyses across all major cancer cell line pharmacogenomic data sources from NCI-DTP NCI-60, Sanger GDSC, and Broad CCLE/CTRP | Skip over navigation CellMiner NCI-60 NCI/DCTD/DTP",
        "homepage": "http://discover.nci.nih.gov/cellminercdb",
        "name": "RESULTS:CellMinerCDB"
    }
}